The overall heart failure-related mortality rate in the United States has almost doubled in the past two decades. Which patients will benefit the most from the use of ICDs? Join our panel of experts, Drs Abraham, Fonarow, Francis, and Gold as they discuss the latest evidence from clinical trials.

Drs Lindsay, Brugada, Gold and Stein highlight the most recent clinical trial data demonstrating the efficacy and safety of ICDs and cardiac resynchronization therapy (CRT) devices and their potential impact on clinical practice.

Join Drs Saxon, Dixon, Ewald, Gilliam and Margolis as they discuss the issues involved in proving the concept that "networked" patient care improves outcomes. Also learn as they debate on current and future device innovations that will 'close the loop' and help eliminate communication gaps in patient care.